Tylenol Arthritis Pain Caplets on recall
This article was originally published in The Tan Sheet
McNeil Consumer Healthcare expands a voluntary recall of its arthritis analgesic from five lots to all available lots following consumer reports of a moldy odor associated with the product. The Johnson & Johnson unit and FDA said Dec. 18 certain lots of the Tylenol Arthritis Pain product in 100-count bottles had traces of a chemical from treated wooden pallets, though all adverse events associated with the resulting odor have been temporary and non-serious. McNeil said it plans to move production to a new facility and reintroduce the product
You may also be interested in...
McNeil Consumer Healthcare's reaction to signs of potentially contaminated packaging for OTC products including Tylenol raised FDA's ire and is now costing the firm an extensive product recall
Sandoz has heralded a “new era as a standalone global leader and European champion in generic and biosimilar medicines” after completing its long journey towards independence by separating from former parent company Novartis.
The former principal deputy commissioner outlined what she sees as the future data requirements for real world evidence and why cell and gene therapy will lead the way.